Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial
- Resource Type
- Authors
- Grace K. Sohn; A. Mirza; Jean Y. Tang; Kavita Y. Sarin; Anthony E. Oro; Gina P. Kwon; I. Bailey-Healy
- Source
- JAMA Dermatol
- Subject
- medicine.medical_specialty
business.industry
Itraconazole
Placebo-controlled study
Basal Cell Nevus Syndrome
Dermatology
medicine.disease
Gastroenterology
030207 dermatology & venereal diseases
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
Research Letter
Basal cell
In patient
Basal cell carcinoma
Open label
business
medicine.drug
- Language
- ISSN
- 2168-6084
This phase 2, open-label, placebo-controlled examines topical itraconazole as a treatment for basal cell carcinoma.